MOLL FREDERIC H 4
4 · PROCEPT BioRobotics Corp · Filed Jun 10, 2026
Research Summary
AI-generated summary of this filing
PROCEPT (PRCT) Director Frederic H. Moll Receives RSU & Option Award
What Happened
Frederic H. Moll, a director of PROCEPT BioRobotics Corp (PRCT), received equity awards on June 9, 2026: 3,315 restricted stock units (RSUs) and a derivative award covering 5,853 shares. Both awards were reported at $0.00 on the Form 4 (i.e., no cash paid by the insider). Combined, the awards cover 9,168 shares and are subject to vesting conditions rather than representing immediately transferable shares.
Key Details
- Transaction date: 2026-06-09; filing date/accession: 2026-06-10 (timely filing).
- Awards: 3,315 RSUs (F1) and 5,853 derivative award (stock option per F2); reported price $0.00.
- Vesting: Per footnotes — RSUs and the stock option vest in full on the earlier of (i) one-year anniversary of the grant or (ii) the next annual meeting, subject to continued service.
- Shares owned after transaction: Not specified in the provided filing.
- This was an award/grant (code A) — a compensation/benefit transaction, not an open-market purchase or sale.
Context
RSUs and option grants are common director/executive compensation and do not by themselves indicate buying or selling sentiment; they represent future rights to stock contingent on vesting and continued service. The option referenced (F2) vests on a similar one-year/annual-meeting schedule; it was granted but not exercised.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-09+3,315→ 866,474 total - Award
Stock Option (Right to Buy)
[F2]2026-06-09+5,853→ 5,853 totalExercise: $28.78Exp: 2036-06-08→ Common Stock (5,853 underlying)
Footnotes (2)
- [F1]These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.
- [F2]The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.